Stockreport

Cadrenal Therapeutics GAAP EPS of -$1.31 beats by $0.18 [Seeking Alpha]

Cadrenal Therapeutics, Inc.  (CVKD) 
PDF The Company had approximately 2.1 million shares of common stock outstanding as of September 30, 2025. More on Cadrenal Therapeutics Seeking Alpha's Quant Rating on [Read more]